窪田製薬ホールディングス(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4596/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2018/02/09 | 日証協 | 294,900株 | +30.54% | 41,900株 | -66.56% | 302,381株 | +5.99% | 7,800株 | -83.01% |
| 2018/02/02 | 日証協 | 225,900株 | +19.71% | 125,300株 | +217.22% | 285,281株 | +7.99% | 45,900株 | +12.77% |
| 2018/01/26 | 日証協 | 188,700株 | -8.53% | 39,500株 | -60.42% | 264,181株 | -0.87% | 40,704株 | -5.14% |
| 2018/01/19 | 日証協 | 206,300株 | +50.47% | 99,800株 | +379.81% | 266,492株 | +16.57% | 42,910株 | +335.77% |
| 2018/01/12 | 日証協 | 137,100株 | -33.86% | 20,800株 | 0% | 228,612株 | -10.93% | 9,847株 | +146.18% |
| 2018/01/05 | 日証協 | 207,300株 | -0.43% | 0株 | -100% | 256,665株 | +1.77% | 4,000株 | -57.51% |
| 2017/12/29 | 日証協 | 208,200株 | -1% | 1,000株 | +25% | 252,204株 | -3.72% | 9,415株 | -52.73% |
| 2017/12/22 | 日証協 | 210,300株 | -10.62% | 800株 | -98.09% | 261,940株 | -2.85% | 19,919株 | +563.97% |
| 2017/12/15 | 日証協 | 235,300株 | -3.33% | 41,900株 | +4.23% | 269,621株 | -1.53% | 3,000株 | +30.21% |
| 2017/12/08 | 日証協 | 243,400株 | -10.97% | 40,200株 | +2015.79% | 273,821株 | -4.3% | 2,304株 | -78.26% |
| 2017/12/01 | 日証協 | 273,400株 | -6.34% | 1,900株 | -95.16% | 286,117株 | -2.49% | 10,600株 | +1216.77% |
| 2017/11/24 | 日証協 | 291,900株 | -0.1% | 39,253株 | 0% | 293,417株 | +0.55% | 805株 | -80.41% |
| 2017/11/17 | 日証協 | 292,200株 | -2.14% | 0株 | -100% | 291,802株 | -2.34% | 4,110株 | -55.33% |
| 2017/11/10 | 日証協 | 298,600株 | +2.19% | 17,600株 | +375.68% | 298,792株 | -0.7% | 9,200株 | +154.85% |
| 2017/11/02 | 日証協 | 292,200株 | -0.58% | 3,700株 | -92.31% | 300,892株 | -0.72% | 3,610株 | -50.55% |
| 2017/10/27 | 日証協 | 293,900株 | +1.91% | 48,100株 | +743.86% | 303,082株 | +1.27% | 7,300株 | +17.55% |
| 2017/10/20 | 日証協 | 288,400株 | +0.66% | 5,700株 | -86.68% | 299,282株 | +0.91% | 6,210株 | +148.4% |
| 2017/10/13 | 日証協 | 286,500株 | -1.48% | 42,800株 | -4.04% | 296,572株 | -0.4% | 2,500株 | -46.85% |
| 2017/10/06 | 日証協 | 290,800株 | +1.86% | 44,600株 | -69.8% | 297,772株 | +0.92% | 4,704株 | -92.53% |
※株式分割は考慮していませんのでご注意ください。
Page Top